Literature DB >> 3949980

Pathways of adenine nucleotide catabolism in erythrocytes.

F Bontemps, G Van den Berghe, H G Hers.   

Abstract

The exact pathway whereby the initial catabolism of the adenine nucleotides proceeds from AMP and the possibility of a recycling of adenosine were investigated in human erythrocytes. Adenine nucleotide catabolism, reflected by the production of hypoxanthine, is very slow under physiologic conditions and can be greatly increased by suppression of glucose or alkalinization of the medium. Experiments with inhibitors of adenosine deaminase and adenosine kinase demonstrated that under physiologic conditions the initial catabolism of AMP proceeds by way of a deamination of AMP, followed by dephosphorylation of inosine monophosphate, and that no recycling occurs between AMP and adenosine. Under glucose deprivation, approximately 75% of the 20-fold increase of the catabolism of the adenine nucleotides proceeded by way of a dephosphorylation of AMP followed by deamination of adenosine, and a small recycling of this nucleoside could be evidenced. Inhibition of adenosine transport showed that the dephosphorylation of AMP occurred intracellularly. When the incubation medium was alkalinized in the presence of glucose, the 15-fold increase in the conversion of AMP to hypoxanthine proceeded exclusively by way of AMP deaminase but a small recycling of adenosine could also be evidenced. The threefold elevation of intraerythrocytic inorganic phosphate (Pi) during glucose deprivation and its 50% decrease during alkalinization as well as experiments in which extracellular Pi was modified, indicate that the dephosphorylation of red blood cell AMP is mainly responsive to variations of AMP, whereas its deamination is more sensitive to Pi.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949980      PMCID: PMC423468          DOI: 10.1172/JCI112379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  INORGANIC PHOSPHATE AND ENHANCED GLUCOSE DEGRADATION BY THE INTACT ERYTHROCYTE.

Authors:  K K TSUBOI; K FUKUNAGA
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

2.  Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject.

Authors:  M A Lichtman; D R Miller; R B Freeman
Journal:  N Engl J Med       Date:  1969-01-30       Impact factor: 91.245

3.  Role of inorganic phosphate in stimulating the glucose utilization of human red blood cells.

Authors:  I A Rose; J V Warms; E L O'Connell
Journal:  Biochem Biophys Res Commun       Date:  1964-02-18       Impact factor: 3.575

4.  The influence of pH and methylene blue on the pathways of glucose utilization and lactate formation in erythrocytes of man.

Authors:  V Albrecht; H Roigas; M Schultze; G Jacobasch; S Rapoport
Journal:  Eur J Biochem       Date:  1971-05-11

5.  Inhibitors of nucleoside and nucleotide metabolism.

Authors:  J F Henderson; A R Paterson; I C Caldwell; B Paul; M C Chan; K F Lau
Journal:  Cancer Chemother Rep 2       Date:  1972-11

6.  Regulation of AMP deaminase by 2,3-diphosphoglyceric acid: a possible mechanism for the control of adenine nucleotide metabolism in human erythrocytes.

Authors:  A Askari; S N Rao
Journal:  Biochim Biophys Acta       Date:  1968-01-08

7.  Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: relationship to extracellular phosphate concentration.

Authors:  M A Lichtman; D R Miller
Journal:  J Lab Clin Med       Date:  1970-08

8.  Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro.

Authors:  G W Crabtree; J F Henderson
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

9.  A new micromethod for the colorimetric determination of inorganic phosphate.

Authors:  K Itaya; M Ui
Journal:  Clin Chim Acta       Date:  1966-09       Impact factor: 3.786

10.  Modifying effects of anions on the alkali-cation-activated AMP deaminase of human erythrocyte.

Authors:  A Askari
Journal:  Mol Pharmacol       Date:  1966-11       Impact factor: 4.436

View more
  16 in total

1.  Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency.

Authors:  D R Wagner; J Felbel; U Gresser; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-04-04

2.  Accelerated degradation of adenine nucleotide in erythrocytes of patients with chronic renal failure.

Authors:  M Marlewski; R T Smolenski; M Szolkiewicz; Z Aleksandrowicz; B Rutkowski; J Swierczynski
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

3.  Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers.

Authors:  J B Matthews; K J Tally; J A Smith; A J Zeind; B J Hrnjez
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Adenine nucleotide metabolism in isolated chicken hepatocytes.

Authors:  J Spychała; G Van den Berghe
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

5.  Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro.

Authors:  P A Berman; L Human; J A Freese
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase.

Authors:  G van Waeg; G Van den Berghe
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes.

Authors:  Richard L Sabina; Nancy J Wandersee; Cheryl A Hillery
Journal:  Br J Haematol       Date:  2008-11-19       Impact factor: 6.998

8.  Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.

Authors:  F Javaux; M F Vincent; D R Wagner; G van den Berghe
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

9.  Regulation of platelet AMP deaminase activity in situ.

Authors:  A J Verhoeven; J Marszalek; H Holmsen
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

10.  5'-Nucleotidase activities in human erythrocytes. Identification of a purine 5'-nucleotidase stimulated by ATP and glycerate 2,3-bisphosphate.

Authors:  F Bontemps; G Van den Berghe; H G Hers
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.